N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia

Pharmacology, Toxicology and Pharmaceutical Science

• Omega-3 Fatty Acid 100%
• Fatty Acid 100%
• Dysglycemia 100%
• Placebo 57%
• Heart Arrhythmia 14%
• Heart Infarction 14%
• Triacylglycerol 14%
• Insulin Glargine 14%
• Congestive Heart Failure 14%
• Impaired Glucose Tolerance 14%
• Non Insulin Dependent Diabetes Mellitus 14%

INIS

• patients 100%
• fatty acids 100%
• hazards 36%
• risks 27%
• death 27%
• comparative evaluations 18%
• glucose 18%
• levels 9%
• design 9%
• origin 9%
• fasting 9%
• insulin 9%
• triglycerides 9%
• heart failure 9%
• esters 9%
• diabetes mellitus 9%
• lipids 9%
• capsules 9%
• myocardial infarction 9%
• tolerance 9%

Keyphrases

• N-3 Fatty Acids 100%
• Daily Supplementation 14%
• Major Vascular Injury 14%
• Sanofi 14%
• Recent Myocardial Infarction 14%
• Arrhythmia 14%